EVALUATION OF THE CLINICAL EFFECT OF SIMVASTATIN IN PATIENTS WITH UNSTABLE ANGINA AT A YOUNG AGE
Keywords:
CHD, young age, atherosclerosisAbstract
The clinical effect of rosuvostatin in patients with coronary heart disease (CHD) at young age was studied. We examined 120 patients with CHD aged 18 to 44 years (mean age 32.0±5.0 years). All patients underwent history taking, anthropometry, general clinical, laboratory, biochemical (lipid spectrum) and instrumental examinations. The obtained analysis of lipid profile in patients with IHD showed that simvastatin in the daily dose of 20 mg in 3 months showed hypolipidemic effect with good tolerability
Downloads
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.